Dyne Therapeutics, Inc. - COM (DYN)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
111M
Holdings value Q2 2024
$3.92B
Value change Q2 2024
+$557M
Grand Portfolio weight change Q2 2024
+0.001%
Number of holders
191
Number of buys Q2 2024
39
Number of sells Q2 2024
-29
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.89M $103M -$19M $35.92 56
2024 Q2 111M $3.92B +$557M $35.29 192
2024 Q1 95.3M $2.71B +$786M $28.39 168
2023 Q4 68.9M $916M +$53.2M $13.30 123
2023 Q3 59.9M $537M +$1.69M $8.96 115
2023 Q2 59.2M $666M +$50.9M $11.25 117
2023 Q1 54.6M $629M +$56.5M $11.52 125
2022 Q4 49.7M $576M +$50.1M $11.59 111
2022 Q3 44.5M $565M -$9.02M $12.70 99
2022 Q2 46.7M $321M -$8.06M $6.87 87
2022 Q1 47.3M $455M -$4.23M $9.64 90
2021 Q4 47.8M $568M +$18.9M $11.89 90
2021 Q3 32.3M $525M -$16.4M $16.24 80
2021 Q2 35.8M $753M +$36.1M $21.04 75
2021 Q1 31.4M $487M +$72.4M $15.53 72
2020 Q4 26.3M $552M +$28.8M $21.00 67
2020 Q3 24.5M $494M +$494M $20.19 49